Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Great Lakes Chemical Corp.
Company sells WIL Research Laboratories to Behrman Capital
November 6th, 2004
Great Lakes Chemical Corp. (GLK), a producer of specialty chemicals and consumer products, and Behrman Capital, a private equity investment firm based in New York, New York and San Francisco, California, announced the sale of Great Lakes' toxicological services business, WIL Research Laboratories (WIL), to Behrman for $105 million in proceeds. "Divesting WIL Research Laboratories supports the company's strategy to focus on our core industrial and consumer businesses," said Great Lakes Chairman and CEO Mark Bulriss. "WIL is a tremendous asset with a highly skilled team, and this move positions WIL more favorably for growth in the life sciences arena." ...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
